Mirum Pharmaceuticals, Inc. (MIRM): Depreciation & Amortization
$24.24M
Year ended 2025-12-31
$25.95M
Trailing 12 months to 2026-06-30
+95.6%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.24M | +2.6% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $23.63M | +118.2% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $10.83M | +234.4% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $3.24M | +444.2% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $595.0K | +95.1% | 2024-03-15, From 2021-01-01 |
| 2020-12-31 | $305.0K | +119.4% | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | $139.0K | n/a | 2021-03-09, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
Compare MIRM, BBIO, HCM, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗